Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
class of compounds
|
| gptkbp:administeredBy |
intravenous injection
|
| gptkbp:class |
antimicrobial
|
| gptkbp:contains |
peptide
carbohydrate |
| gptkbp:discoveredIn |
1950s
|
| gptkbp:example |
gptkb:teicoplanin
gptkb:dalbavancin gptkb:oritavancin gptkb:telavancin vancomycin |
| https://www.w3.org/2000/01/rdf-schema#label |
Glycopeptides
|
| gptkbp:mechanismOfAction |
inhibits cell wall synthesis
|
| gptkbp:notEffectiveAgainst |
Gram-negative bacteria
|
| gptkbp:sideEffect |
gptkb:red_man_syndrome
nephrotoxicity ototoxicity |
| gptkbp:target |
D-Ala-D-Ala terminus of peptidoglycan precursors
|
| gptkbp:usedAs |
gptkb:antibiotic
|
| gptkbp:usedFor |
Gram-positive bacterial infections
|
| gptkbp:usedIn |
hospital settings
|
| gptkbp:bfsParent |
gptkb:Antibiotics
|
| gptkbp:bfsLayer |
4
|